Cytiva News
-
Ribobay Pharma Boosts CRDMO Offerings With Cytiva's First FlexFactory Platform For Oligonucleotides
5/15/2024
Ribobay Pharma, a leading Chinese biopharmaceutical contract research, development, and manufacturing organization (CRDMO) and a spin-off company of General Biol (Anhui) Co., Ltd, will provide cGMP-level oligonucleotide (oligo) CRDMO services to the world using Cytiva’s first FlexFactory platform for oligo manufacturing.
-
Cytiva Opens Cell Culture Center Of Excellence In Massachusetts
11/9/2022
Global life sciences leader Cytiva opened a new Cell Culture Center of Excellence at its Marlborough, Massachusetts location.
-
Cytiva Strengthens Cell Line Development With CEVEC Acquisition
10/6/2022
Global life sciences leader Cytiva has acquired CEVEC Pharmaceuticals, a leading German provider of high-performance cell line development and viral vector manufacturing technologies. CEVEC will further strengthen Cytiva's leading position in biomanufacturing solutions.
-
Cytiva Expanding US Operations
7/13/2022
The new chromatography resins manufacturing site is part of Cytiva and Pall Corporation’s 1.5 billion USD capacity expansion investment.
-
Cytiva To provide Arranta Bio 'Idea To Injection' solutions For integrated Manufacturing Of mRNA Products
1/25/2022
Cytiva, a global life sciences leader, will provide its FlexFactory single-use manufacturing platform to Arranta Bio ("Arranta"), a leading contract development and manufacturing organization (CDMO) for use in manufacturing mRNA vaccines.
-
Cytiva Attains Business Continuity Management System ISO Certification
1/11/2022
The new ISO 22301:2019 certification covers methods and procedures for maintaining emergency response, crisis management, and business continuity capabilities, including communication, implementation, and continual improvement.
-
Cytiva Acquires GoSilico To Strengthen Digital Capabilities In Bioprocessing
6/2/2021
Global life sciences leader Cytiva has acquired the German scientific software maker GoSilico, in a move that will differentiate Cytiva as a premier partner in bioprocessing.
-
Cytiva Acquires Vanrx Pharmasystems, Canadian Aseptic Filling Innovator
2/1/2021
Cytiva has acquired Vanrx Pharmasystems, a Canadian company that makes robotic aseptic filling machines to fill vials, syringes, and cartridges with reduced risk and increased speed to patients.
-
Cytiva Delivers KUBio To Lonza
1/14/2021
Cytiva, a global life sciences leader, has successfully completed another KUBio installation, this time to global healthcare solutions provider Lonza, in Guangzhou Biopark, China.
-
Cytiva Provides Akron Biotech With FlexFactory For The Manufacture Of Plasmid DNA
10/15/2020
Cytiva, a global life sciences leader, will provide its FlexFactory to Akron Biotech, a leading provider of cGMP-compliant solutions to support advanced therapy development.